Cargando…
Aureolic Acid Group of Agents as Potential Antituberculosis Drugs
Mycobacterium tuberculosis is one of the most dangerous pathogens. Bacterial resistance to antituberculosis drugs grows each year, but searching for new drugs is a long process. Testing for available drugs to find active against mycobacteria may be a good alternative. In this work, antibiotics of th...
Autores principales: | Bespyatykh, Julia, Bespiatykh, Dmitry, Malakhova, Maja, Klimina, Ksenia, Bespyatykh, Andrey, Varizhuk, Anna, Tevyashova, Anna, Nikolenko, Tatiana, Pozmogova, Galina, Ilina, Elena, Shitikov, Egor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650759/ https://www.ncbi.nlm.nih.gov/pubmed/33086595 http://dx.doi.org/10.3390/antibiotics9100715 |
Ejemplares similares
-
Genome-Wide Transcriptional Response of Mycobacterium smegmatis MC(2)155 to G-Quadruplex Ligands BRACO-19 and TMPyP4
por: Shitikov, Egor, et al.
Publicado: (2022) -
Substitutions in SurA and BamA Lead to Reduced Susceptibility to Broad Range Antibiotics in Gonococci
por: Bodoev, Ivan, et al.
Publicado: (2021) -
Metabolic Changes of Mycobacterium tuberculosis during the Anti-Tuberculosis Therapy
por: Bespyatykh, Julia, et al.
Publicado: (2020) -
Author Correction: System OMICs analysis of Mycobacterium tuberculosis Beijing B0/W148 cluster
por: Bespyatykh, Julia, et al.
Publicado: (2020) -
System OMICs analysis of Mycobacterium tuberculosis Beijing B0/W148 cluster
por: Bespyatykh, Julia, et al.
Publicado: (2019)